SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-22-001492
Filing Date
2022-02-11
Accepted
2022-02-11 07:20:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 ELEDON PHARMACEUTICALS, INC. p22-0293sc13ga.htm SC 13G/A 48872
  Complete submission text file 0000902664-22-001492.txt   50677
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Subject) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88334 | Film No.: 22616698
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111 415-801-4550
Woodline Partners LP (Filed by) CIK: 0001784547 (see all company filings)

IRS No.: 831749088 | State of Incorp.: DE
Type: SC 13G/A